 Glucose Intolerance
"Glucose Intolerance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
| Descriptor ID |
D018149
|
| MeSH Number(s) |
C18.452.394.952.500
|
| Concept/Terms |
Glucose Intolerance- Glucose Intolerance
- Glucose Intolerances
- Intolerance, Glucose
- Intolerances, Glucose
- Impaired Glucose Tolerance
- Glucose Tolerance, Impaired
- Glucose Tolerances, Impaired
- Impaired Glucose Tolerances
- Tolerance, Impaired Glucose
- Tolerances, Impaired Glucose
|
Below are MeSH descriptors whose meaning is more general than "Glucose Intolerance".
Below are MeSH descriptors whose meaning is more specific than "Glucose Intolerance".
This graph shows the total number of publications written about "Glucose Intolerance" by people in this website by year, and whether "Glucose Intolerance" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1996 | 1 | 0 | 1 | | 1997 | 0 | 1 | 1 | | 1999 | 1 | 0 | 1 | | 2000 | 1 | 2 | 3 | | 2003 | 1 | 1 | 2 | | 2004 | 0 | 1 | 1 | | 2005 | 1 | 2 | 3 | | 2006 | 3 | 0 | 3 | | 2007 | 2 | 1 | 3 | | 2008 | 1 | 3 | 4 | | 2009 | 1 | 2 | 3 | | 2010 | 4 | 3 | 7 | | 2011 | 1 | 2 | 3 | | 2012 | 0 | 4 | 4 | | 2013 | 3 | 0 | 3 | | 2014 | 3 | 4 | 7 | | 2015 | 3 | 1 | 4 | | 2016 | 1 | 2 | 3 | | 2017 | 2 | 1 | 3 | | 2018 | 6 | 2 | 8 | | 2019 | 2 | 2 | 4 | | 2020 | 4 | 2 | 6 | | 2021 | 5 | 2 | 7 | | 2022 | 7 | 1 | 8 | | 2023 | 2 | 0 | 2 | | 2024 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Glucose Intolerance" by people in Profiles.
-
Abushamat LA, Schauer IE, Low Wang CC, Mitchell S, Herlache L, Bridenstine M, Durbin R, Snell-Bergeon JK, Regensteiner JG, Reusch JE. Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study. J Investig Med. 2024 03; 72(3):294-304.
-
Putman MS, Norris AW, Hull RL, Rickels MR, Sussel L, Blackman SM, Chan CL, Ode KL, Daley T, Stecenko AA, Moran A, Helmick MJ, Cray S, Alvarez JA, Stallings VA, Tuggle KL, Clancy JP, Eggerman TL, Engelhardt JF, Kelly A. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes. Diabetes. 2023 06 01; 72(6):677-689.
-
Putman MS, Norris AW, Hull RL, Rickels MR, Sussel L, Blackman SM, Chan CL, Ode KL, Daley T, Stecenko AA, Moran A, Helmick MJ, Cray S, Alvarez JA, Stallings VA, Tuggle KL, Clancy JP, Eggerman TL, Engelhardt JF, Kelly A. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes. Diabetes Care. 2023 06 01; 46(6):1112-1123.
-
James-Allan LB, Rosario FJ, Madi L, Barner K, Nair S, Lai A, Carrion F, Powell TL, Salomon C, Jansson T. A novel technique using chronic infusion of small extracellular vesicles from gestational diabetes mellitus causes glucose intolerance in pregnant mice. Clin Sci (Lond). 2022 11 11; 136(21):1535-1549.
-
Wang Q, Li H, Tajima K, Verkerke ARP, Taxin ZH, Hou Z, Cole JB, Li F, Wong J, Abe I, Pradhan RN, Yamamuro T, Yoneshiro T, Hirschhorn JN, Kajimura S. Post-translational control of beige fat biogenesis by PRDM16 stabilization. Nature. 2022 09; 609(7925):151-158.
-
Utzschneider KM, Ehrmann DA, Arslanian SA, Barengolts E, Buchanan TA, Caprio S, Edelstein SL, Hannon TS, Kahn SE, Kozedub A, Mather KJ, Nadeau KJ, Sam S, Tripputi M, Xiang AH, El Ghormli L. Weight loss and ?-cell responses following gastric banding or pharmacotherapy in adults with impaired glucose tolerance or type 2 diabetes: a randomized trial. Obesity (Silver Spring). 2022 08; 30(8):1579-1588.
-
Kelly AC, J Rosario F, Chan J, Cox LA, Powell TL, Jansson T. Transcriptomic responses are sex-dependent in the skeletal muscle and liver in offspring of obese mice. Am J Physiol Endocrinol Metab. 2022 Oct 01; 323(4):E336-E353.
-
Dumolt J, Powell TL, Jansson T, Rosario FJ. Normalization of maternal adiponectin in obese pregnant mice prevents programming of impaired glucose metabolism in adult offspring. FASEB J. 2022 07; 36(7):e22383.
-
Chun JH, Henckel MM, Knaub LA, Hull SE, Pott GB, Ramirez DG, Reusch JE, Keller AC. (-)-Epicatechin Reverses Glucose Intolerance in Rats Housed at Thermoneutrality. Planta Med. 2022 Aug; 88(9-10):735-744.
-
Eckel RH, Bruce KD. Statins, gut microbiome, LDL-C, glucose intolerance: Personalized medicine timely? Med. 2022 06 10; 3(6):355-357.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|